There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on iTeos Therapeutics (ITOS – Research Report), Verona Pharma (VRNA – Research Report) and vTv Therapeutics (VTVT – Research Report) with bullish sentiments. iTeos Therapeutics (ITOS) In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on iTeos Therapeutics, with a price target of $54.00. The company's shares closed last Friday at $21.49, close to its 52-week low of $16.21. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-iteos-therapeutics-itos-verona-pharma-vrna-and-vtv-therapeutics-vtvt?utm_source=advfn.com&utm_medium=referral
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Jan 2023 to Feb 2023 Click Here for more vTv Therapeutics Charts.
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Feb 2022 to Feb 2023 Click Here for more vTv Therapeutics Charts.